News and Comments

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...


Recent Postings


Archive


Tags

Agenus (AGEN Vitae Pharmaceuticals (VTAE) KERYX (KERX) C4 Therapeutics Auspex (ASPX) Zerenex JOUNCE THERAPEUTICS (JNCE) ARGOS (ARGS) Dynavax (DVAX) Idenix (IDIX) Elan (ELN) Galena (GALE) ARCA (ABIO) OSI (OSIP) Multiple Myeloma TOKAI (TKAOI) INNOVIVA (INVA) Sequenom (SQNM) AstraZeneca (AZN) KITE (KITE) Bristol-Myers Squibb (BMY) BIOMARIN (BMRN) CompuGen (CGEN) MODERNA Pluristem (PSTI) Biocryst (BCRX) Valeant Pharmaceuticals International (VRX) Micromet (MITI) CEMPRA (CEMP) ISIS (ISIS) REGULUS (RGLS) Theravance Bio Pharma (TBPH) Incyte (INCY) PTC Therapeutics (PTCT) NOVOCURE (NVCR) Inovio (INO) Illumina (ILMN) Theravance (THRX) Sanofi (SNY) ImmunoGen (IMGN) Alder Biopharmaceuticals (ALDR) Merck (MRK) Abbott Laboratories (ABT) Sangamo (SGMO) Ariad (ARIA) Xoma (XOMA) ABBVIE (ABBV) Array Pharmaceuticals (ARRY) ZALTRAP™ Gilead (GILD) Ziofpharm (ZIOP) Prolor Biotech (PBTH) Spike Therapeutics (ONCE) Revlimid (lenolidamide) SERES THERAPEUTICS (MCRB) Human Genome Sciences (HGSI) Roche (ROCHE) Jazz Pharmaceuticals (JAZZ) Ionis (IONS) VANDA (VNDA) Editas (EDIT) Intermune (ITMN) Herceptin AERIE PHARMACEUTICALS Regeneron (REGN) Adaptimmune (ADAP) Vertex (VRTX) Velcade (bortezomib) Global Cell Therapeutics (GBT) Benlysta (belimumab) Bellicum (BLCM) GlaxoSmithKline (GSK) NANTKWEST (NK) PORTOLA (PTLA) Ocular Therapeutix (OCUL) SUNESIS PHARMACEUTICALS (SNSS) Telaprevir Endometrial Cancer IDERA (IDRA) ADVENTRIX (ANX) ACADIA (ACAD) SYNTA (SNTA) Tysabri Amgen (AMGN) Anadys (ANDS) Genentech Anacor (ANAC) Prosensa (RNA) Intrexon (XON) Trastuzumab-DM1 Sanofi (SNA) Roche (RHHBY) Dendreon (DNDN) Aimmune Therapeutics (AIMT) Human Longevity (HLI) AGOS (ARGS) Biogen Idec (BIIB) Rapamune NEKTAR (NKTR)) Intercept (ICPT) Exelixis (EXEL) Advaxis (ADXS) Mirati Therapeutics (MRTX) Cytokinetics (CYTK) GUARDIAN HEALTH Seattle Genetics (SGEN) galapagos (GLPG) HALOZYME (HALO) Alnylam (ALNY) CRISPR Therapeutics (CRSP) Sarepta (SRPT) JUNO (JUNO) Agenus (AGEN) Sanofi-Aventis (SAN) RenenxBio (RGNX) Ridaforolimus Onyx (ONXX)